Earnings Feed
Start Free
Home/Filings/4/0001127602-20-013221
4//SEC Filing

MERLO LARRY J 4

Accession 0001127602-20-013221

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:20 PM ET

Size

19.6 KB

Accession

0001127602-20-013221

Insider Transaction Report

Form 4
Period: 2020-04-01
CVS HEALTH CorpCVS
MERLO LARRY J
Executive Vice President
Transactions
  • Award

    Stock Option

    2020-04-01$58.61/sh+478,711$28,057,252→ 478,711 total
    Exercise: $58.61From: 2021-04-01Exp: 2030-04-01→ Common Stock (478,711 underlying)
  • Tax Payment

    Common Stock

    2020-04-01$58.34/sh−8,868$517,359→ 510,054.941 total
Holdings

  • Common Stock

    (indirect: By Trust)
    393,960.72

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (286,787 underlying)
    286,787

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (338,105 underlying)
    338,105

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (5,151.999 underlying)
    5,151.999

  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (273,929 underlying)
    273,929

  • Stock Unit

    669,868.744

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (394,091 underlying)
    394,091

  • Common Stock (restricted)

    62,321

  • Stock Option

    Exercise: $74.29From: 2015-04-01Exp: 2021-04-01→ Common Stock (335,697 underlying)
    335,697

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (545,419 underlying)
    545,419

  • ESOP Common Stock

    (indirect: By ESOP)
    11,173.344
Footnotes (12)
  • [F1]Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
  • [F10]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F11]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F12]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F2]The number of shares subject to the option were calculated using a 30-day average price.
  • [F3]Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
  • [F4]Each share credit is equivalent to one share; 1-for-1 conversion.
  • [F5]Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F6]Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2015.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F9]Option became exercisable in four equal annual installments, commencing 4/1/2017.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001194413

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:20 PM ET
Size
19.6 KB
View on SEC.gov